Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

AlgoraeOS

  • Home
  •  
  • AlgoraeOS



  • Most Read
  • Latest Comments
  • How Algorae is using AI and supercomputers to transform medicine
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • How Algorae is using AI and supercomputers to transform medicine
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • How Algorae is using AI and supercomputers to transform medicine
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • How Algorae is using AI and supercomputers to transform medicine
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • How Algorae is using AI and supercomputers to transform medicine
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • Spacetalk Leverages AI to Help Wearables PredictHealth Risks
    Spacetalk Leverages AI to Help Wearables PredictHealth Risks
    • News

  • UNITH launches self-service Digital Human Platform ‘interFace’ with strong early traction
    UNITH launches self-service Digital Human Platform ‘interFace’ with strong early traction
    • News

  • City of Calgary engages SenSen for more smart city tech
    City of Calgary engages SenSen for more smart city tech
    • News

  • Interest in captioning tech sees jump in earnings for AI-Media
    Interest in captioning tech sees jump in earnings for AI-Media
    • News

  • AI-powered road safety solutions pave the way for Acusensus revenue bump
    AI-powered road safety solutions pave the way for Acusensus revenue bump
    • News

  • How Algorae is using AI and supercomputers to transform medicine
    • News

    How Algorae is using AI and supercomputers to transform medicine

    The conversations surrounding artificial intelligence (AI) and its scope to transform the pharma industry have been underway for a while now. In fact, reports suggest that the global health-related AI market is set to be worth $284bn by 2030.  Pharmaceutical development company Algorae (ASX: 1AI) is one of the companies at the forefront of this

    Read More
    Public
  • Algorae teams up with HL Pharma to supply cannaboids for research projects
    • News

    Algorae teams up with HL Pharma to supply cannaboids for research projects

    Aussie pharma development company Algorae Pharmaceuticals (ASX: 1AI) has partnered with HL Pharma, an Australian company registered with the Victorian Department of Health, for the sourcing, supply, and distribution of various cannabinoid compounds for research purposes. The collaboration is governed by a comprehensive three-year agreement, adhering to Good Distribution Practice (GDP). Under the terms, HL

    Read More
    Public
  • Algorae Pharmaceuticals collaborates with UNSW for AI biopharmaceutical prediction platform for dementia and heart diseases
    • News

    Algorae Pharmaceuticals collaborates with UNSW for AI biopharmaceutical prediction platform for dementia and heart diseases

    As of 2023, over 400,000 Australians live with dementia, with over a million people assigned to their care. It is the second leading cause of death in the country overall and the leading cause of death in women. What’s worse, Australia’s growing ageing population makes this statistic all the more worrying.  In a bid to

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.